These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
853 related items for PubMed ID: 19513506
1. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line. Wen J, Zheng B, Hu Y, Zhang X, Yang H, Luo KJ, Zhang X, Li YF, Fu JH. Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506 [Abstract] [Full Text] [Related]
2. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1. Wang TH, Wan JY, Gong X, Li HZ, Cheng Y. Oncol Rep; 2012 Nov; 28(5):1681-6. PubMed ID: 22941407 [Abstract] [Full Text] [Related]
3. [Comparison of stepwise and pulse induced cisplatin-resistant ovarian cancer cell sublines]. Cheng G, Li Y, Tian F. Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):305-8. PubMed ID: 11783113 [Abstract] [Full Text] [Related]
4. Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: in vivo and clinical studies. Sun Z, Zhao Z, Li G, Dong S, Huang Z, Ye L, Liang H, Qu J, Ai X, Zhang W, Chen X. Tumori; 2010 Jul; 96(1):90-6. PubMed ID: 20437864 [Abstract] [Full Text] [Related]
5. Establishment and characterization of a paclitaxel‑resistant human esophageal carcinoma cell line. Wang C, Guo LB, Ma JY, Li YM, Liu HM. Int J Oncol; 2013 Nov; 43(5):1607-17. PubMed ID: 24002547 [Abstract] [Full Text] [Related]
6. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance. Li G, Chen X, Wang Q, Xu Z, Zhang W, Ye L. J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289 [Abstract] [Full Text] [Related]
7. Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel. Takara K, Obata Y, Yoshikawa E, Kitada N, Sakaeda T, Ohnishi N, Yokoyama T. Cancer Chemother Pharmacol; 2006 Dec; 58(6):785-93. PubMed ID: 16534613 [Abstract] [Full Text] [Related]
8. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity. David-Beabes GL, Overman MJ, Petrofski JA, Campbell PA, de Marzo AM, Nelson WG. Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791 [Abstract] [Full Text] [Related]
9. Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells. To KK, Yu L, Liu S, Fu J, Cho CH. Mol Carcinog; 2012 Jun; 51(6):449-64. PubMed ID: 21678497 [Abstract] [Full Text] [Related]
10. A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levels. Tonigold M, Rossmann A, Meinold M, Bette M, Märken M, Henkenius K, Bretz AC, Giel G, Cai C, Rodepeter FR, Beneš V, Grénman R, Carey TE, Lage H, Stiewe T, Neubauer A, Werner JA, Brendel C, Mandic R. J Cancer Res Clin Oncol; 2014 Oct; 140(10):1689-704. PubMed ID: 24913304 [Abstract] [Full Text] [Related]
11. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line. Wang NN, Zhao LJ, Wu LN, He MF, Qu JW, Zhao YB, Zhao WZ, Li JS, Wang JH. Asian Pac J Cancer Prev; 2013 Oct; 14(9):4983-8. PubMed ID: 24175763 [Abstract] [Full Text] [Related]
12. Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias. Beck JF, Brügger D, Brischwein K, Liu C, Bader P, Niethammer D, Gekeler V. Jpn J Cancer Res; 2001 Aug; 92(8):896-903. PubMed ID: 11509123 [Abstract] [Full Text] [Related]
13. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response. Burger H, Foekens JA, Look MP, Meijer-van Gelder ME, Klijn JG, Wiemer EA, Stoter G, Nooter K. Clin Cancer Res; 2003 Feb; 9(2):827-36. PubMed ID: 12576456 [Abstract] [Full Text] [Related]
14. Expression of multidrug resistance-related transporters in human breast carcinoma. Kanzaki A, Toi M, Nakayama K, Bando H, Mutoh M, Uchida T, Fukumoto M, Takebayashi Y. Jpn J Cancer Res; 2001 Apr; 92(4):452-8. PubMed ID: 11346468 [Abstract] [Full Text] [Related]
15. Establishment and characterization of a cisplatin‑resistant human osteosarcoma cell line. Han T, Zhu X, Wang J, Zhao H, Ma Q, Zhao J, Qiu X, Fan Q. Oncol Rep; 2014 Sep; 32(3):1133-9. PubMed ID: 25017716 [Abstract] [Full Text] [Related]
16. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues]. Yuan SQ, Zhou ZW, Liang YJ, Fu LW, Chen G, Qiu HB, Zhang LY. Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910 [Abstract] [Full Text] [Related]
17. Chronic exposure of human glioblastoma tumors to low concentrations of a pesticide mixture induced multidrug resistance against chemotherapy agents. Doğanlar O, Doğanlar ZB, Kurtdere AK, Chasan T, Ok ES. Ecotoxicol Environ Saf; 2020 Oct 01; 202():110940. PubMed ID: 32800223 [Abstract] [Full Text] [Related]
18. A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells. Hu Y, Stephen AG, Cao J, Tanzer LR, Slapak CA, Harrison SD, Devanarayan V, Dantzig AH, Starling JJ, Rome LH, Moore RE. Int J Cancer; 2002 Jan 10; 97(2):149-56. PubMed ID: 11774257 [Abstract] [Full Text] [Related]
19. Establishment of a human hepatoma multidrug resistant cell line in vitro. Zhou Y, Ling XL, Li SW, Li XQ, Yan B. World J Gastroenterol; 2010 May 14; 16(18):2291-7. PubMed ID: 20458768 [Abstract] [Full Text] [Related]
20. Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo. Stein U, Walther W, Lemm M, Naundorf H, Fichtner I. Int J Cancer; 1997 Sep 04; 72(5):885-91. PubMed ID: 9311609 [Abstract] [Full Text] [Related] Page: [Next] [New Search]